Marko Babjuk
Department of Urology
General Teaching Hospital
1st Medical Faculty
Charles University
Czech Republic
Name/email consistency: high
- Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder. Babjuk, M., Soukup, V., Mares, J., Dusková, J., Pecen, L., Pesl, M., Pavlík, I., DvorRcek, J. Urology (2006)
- 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. Babjuk, M., Soukup, V., Petrík, R., Jirsa, M., Dvorácek, J. BJU Int. (2005)
- Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder. Babjuk, M., Kostírová, M., Mudra, K., Pecher, S., Smolová, H., Pecen, L., Ibrahim, Z., Dvorácek, J., Jarolím, L., Novák, J., Zima, T. Eur. Urol. (2002)
- The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome. Babjuk, M., Soukup, V., Mares, J., Dusková, J., Sedlácek, Z., Trková, M., Pecen, L., Dvorácek, J., Hanus, T., Kocvara, R., Novák, J., Povýsil, C. Int. Urol. Nephrol (2002)
